Bone Versus Visceral Metastases in mCRPC

preview_player
Показать описание
Daniel J. George, MD, provides an overview of common sites of metastasis in patients with metastatic castration-resistant prostate cancer (mCRPC) and suggests how novel imaging techniques can be used to diagnose and manage patients who develop metastatic disease.

  1. Targeted Oncology
  2. targeted oncology
  3. oncology
  4. cancer
Рекомендации по теме
Bone Versus Visceral 0:05:47

Bone Versus Visceral Metastases in mCRPC

Managing Bone Metastasis 0:05:57

Managing Bone Metastasis in Patients With mCRPC

Bisphosphonates vs. RANK 0:20:36

Bisphosphonates vs. RANK ligand inhibition in bone metastases

Bone Metastases and 0:19:01

Bone Metastases and Mortality

New bone-in technique 0:02:42

New bone-in technique tests therapies for breast cancer metastasis

Metastatic Bone Disease 1:01:47

Metastatic Bone Disease

HR+ breast cancer 0:03:58

HR+ breast cancer and visceral metastases - video abstract 72592

Bone metastases: Role 0:17:23

Bone metastases: Role of zoledronic acid, denosumab and other strategies

Bone & Soft 1:10:40

Bone & Soft Tissue Pathology Board Review 2025-05-12

Case 2: Challenges 0:06:11

Case 2: Challenges Treating CSPC With Visceral Metastases

Diffusion MRI for 0:28:38

Diffusion MRI for bone metastases

Staging of locally 0:23:19

Staging of locally advanced prostate cancer - the need to retain bone and CT scans

Contemporary Management of 1:09:29

Contemporary Management of Appendicular Skeletal Metastasis by Primary Tumor Type

WB-MRI - role 0:18:39

WB-MRI - role in high precision medicine for bone metastases

Understanding Nonmetastatic CRPC 0:02:22

Understanding Nonmetastatic CRPC

introduction diagnosis 0:47:35

introduction diagnosis of bone tumors VOICE

Dr. Yardley on 0:01:58

Dr. Yardley on Endocrine Therapy Plus CDK4/6 Inhibitors in Breast Cancer With Visceral Metastases

Dr. Yardley on 0:01:35

Dr. Yardley on Therapy Considerations in Patients With Advanced Breast Cancer/Visceral Metastases

Timing and Optimization 0:13:46

Timing and Optimization of Radium 223 in Castration Resistant Prostate Cancer

Bone Health and 0:23:09

Bone Health and Radionuclide Therapy

Radium-223 Safety Prior 0:03:13

Radium-223 Safety Prior to or After Chemotherapy

Integrating the AUA 0:18:28

Integrating the AUA Guidelines into Your Practice

Prognostic biomarkers for 0:01:12

Prognostic biomarkers for prostate cancer

Liver Visceral Metastasis 0:41:23

Liver Visceral Metastasis Dr Louis A Vandermolen Susan G Komen Orange County MBC Conference 2019

welcome to shbcf.ru